| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/16/2011 | US20110144163 Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents |
| 06/16/2011 | US20110144038 Human cd154-binding synthetic peptide and uses thereof |
| 06/16/2011 | US20110144031 Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same |
| 06/16/2011 | US20110144025 Methods of Reducing Hemorrhage Due to Surgical Procedure |
| 06/16/2011 | US20110144024 Prevention and treatment of radiation injury |
| 06/16/2011 | US20110144021 Therapeutic proteins from latex |
| 06/16/2011 | US20110144020 Treatment of infections and other disorders |
| 06/16/2011 | US20110144017 Protein conjugates and methods for their preparation |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110144013 VEGF-D Mutants and Their Use |
| 06/16/2011 | US20110144012 Shortened glucagon-like peptide 1(sglp-1) preparation method and application |
| 06/16/2011 | US20110144009 Brown Adipocyte Progenitors in Human Skeletal Muscle |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 06/16/2011 | US20110144002 Use of AMPs for Treatment of UTI/Cystitis |
| 06/16/2011 | US20110144000 Antimicrobial polypeptide |
| 06/16/2011 | US20110143999 Fowlicidins and methods of its use |
| 06/16/2011 | US20110143997 Phage receptor binding proteins for antibacterial therapy and other novel uses |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110143954 Gamma-secretase substrate and methods of use |
| 06/16/2011 | US20110143443 Isolsted Monoclonal - Associated Protein Tau and Kit |
| 06/16/2011 | US20110143424 Recombinant influenza viruses for vaccines and gene therapy |
| 06/16/2011 | US20110143422 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 06/16/2011 | US20110143387 Highly water-soluble, cationic luminescent labels |
| 06/16/2011 | US20110143377 Protein fragments of virB10 and sero-detection of anaplasma phagocytophium |
| 06/16/2011 | US20110143370 Nucleic Acids Encoding a Mammalian Raptor Polypeptide and Uses Therefor |
| 06/16/2011 | US20110142989 Hydrolysed Casein Product Comprising Tripeptides IPP and/or VPP |
| 06/16/2011 | US20110142911 HIV epitopes and pharmaceutical composition containing same |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142874 Compositions, Methods, and Kits for Eliciting an Immune Response |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/16/2011 | US20110142861 Depletion of cd103 expressing cells for treatment of disorders |
| 06/16/2011 | US20110142860 Depletion of CD103 Expressing Cells for Treatment of Disorders |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | US20110142841 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142792 Compositions for Increasing Polypeptide Stability and Activity, and Related Methods |
| 06/16/2011 | US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues |
| 06/16/2011 | US20110142762 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 06/16/2011 | US20110142756 Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer |
| 06/16/2011 | DE102009058169A1 Protein oder Polypeptid zur Bindung an Tubulin und/oder Mikrotubulistrukturen Protein or polypeptide to bind to tubulin and / or Mikrotubulistrukturen |
| 06/16/2011 | CA2836117A1 Oncolytic rhabdovirus |
| 06/16/2011 | CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment |
| 06/16/2011 | CA2783763A1 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | CA2783691A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/16/2011 | CA2783669A1 Compositions comprising zinc finger domains and uses therefor |
| 06/16/2011 | CA2782640A1 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 06/16/2011 | CA2782420A1 Human antigen binding proteins that bind .beta.-klotho, fgf receptors and complexes thereof |
| 06/16/2011 | CA2782298A1 Stomata-increasing agent, polypeptide, method for increasing number and/or density of stomata in plant, and method for increasing yield of plant |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | CA2779562A1 Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target |
| 06/15/2011 | EP2333552A1 Novel biomarkers for nonalcoholic fatty liver disease and methods for detecting nonalcoholic fatty liver disease using biomarker |
| 06/15/2011 | EP2333114A1 S. pneumoniae antigens |
| 06/15/2011 | EP2333088A1 Antifungal polypeptides |
| 06/15/2011 | EP2333086A1 Use of a lupinus protein |
| 06/15/2011 | EP2333082A1 Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof |
| 06/15/2011 | EP2333080A1 Methods and means for delaying seed shattering in plants |
| 06/15/2011 | EP2333078A2 Proteins associated with abiotic stress response and homologs |
| 06/15/2011 | EP2333074A1 Substances and methods for the treatment of lysosmal storage diseases |
| 06/15/2011 | EP2333073A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333072A1 Schizochytrium PKS genes |
| 06/15/2011 | EP2333071A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333070A2 Defensin polynucleotides and methods of use |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333062A1 RNA-interference by single-stranded RNA molecules |
| 06/15/2011 | EP2333058A1 Method for promotion of branch formation, dwarfing, sterility and promotion of multiple flower bud formation of plant |
| 06/15/2011 | EP2333045A2 Gene Inactivated Mutants with Altered Protein Production |
| 06/15/2011 | EP2332988A2 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/15/2011 | EP2332987A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/15/2011 | EP2332984A2 Tumor angiogenesis associated genes and a method for their identification |
| 06/15/2011 | EP2332983A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332982A1 Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 06/15/2011 | EP2332981A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332980A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332979A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332977A2 ActRII receptor polypeptides |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332973A2 Differential in tumour gene products and use of same |
| 06/15/2011 | EP2332972A1 Novel Beta-Actin and RPS21 promoters and uses thereof |
| 06/15/2011 | EP2332971A1 Epitope analogs |
| 06/15/2011 | EP2332970A2 Mutated pseudomonas exotoxins with reduced antigenicity |
| 06/15/2011 | EP2332968A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332967A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332966A1 Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332959A2 Method and compositions for detecting botulinum neurotoxin |
| 06/15/2011 | EP2332956A1 Antibody binding to PRO71238 |